3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, David Lau et al.|The Lancet|2017Cited by 843
Bone Fractures and Hypoglycemic Treatment in Type 2 Diabetic PatientsMatteo Monami, Edoardo Mannucci, Barbara Cresci et al.|Diabetes Care|2008Cited by 187